The second National Institutes of Health International Congress on advances in uterine leiomyoma research: conference summary and future recommendations

被引:15
作者
Dixon, Darlene
Parrott, Estella C.
Segars, James H.
Olden, Kenneth
Pinn, Vivian W.
机构
[1] NIH, Off Res Womens Hlth, DHHS, Bethesda, MD 20892 USA
[2] NIEHS, NIH, DHHS, Bethesda, MD 20892 USA
[3] NICHD, NIH, DHHS, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
NIH conference summary; uterine leiomyoma; fibroid; clinical treatment; clinical/basic studies; research recommendations;
D O I
10.1016/j.fertnstert.2006.02.116
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To summarize the proceedings of the Advances in Uterine Leiomyoma Research: 2nd NIH International Congress, which was convened on February 24-25, 2005 by the Department of Health and Human Services (DHHS), National Institutes of Health (NIH) in Bethesda, Maryland. Design: Scientific information was presented at a 2-day conference, which was a collaborative effort of agencies across the DHHS and members of the academic, clinical, and medical communities involved in uterine leiomyoma research. Conclusion(s): The conference brought together scientists in biomedicine, epidemiology, basic research, therapeutics, and translational medicine and fostered an exchange of scientific information among members of the uterine leiomyoma research and health care communities. This document summarizes this exchange and outlines research needs and recommendations for future research directions.
引用
收藏
页码:800 / 806
页数:7
相关论文
共 32 条
[1]  
[Anonymous], AM J EPIDEMIOL
[2]   High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence [J].
Baird, DD ;
Dunson, DB ;
Hill, MC ;
Cousins, D ;
Schectman, JM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 188 (01) :100-107
[3]   Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids [J].
Catherino, WH ;
Leppert, PC ;
Stenmark, MH ;
Payson, M ;
Potlog-Nahari, C ;
Nieman, LK ;
Segars, JH .
GENES CHROMOSOMES & CANCER, 2004, 40 (03) :204-217
[4]   Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis [J].
Chwalisz, K ;
Perez, MC ;
DeManno, D ;
Winkel, C ;
Schubert, G ;
Elger, W .
ENDOCRINE REVIEWS, 2005, 26 (03) :423-438
[5]   Complications in pregnancy, labor, and delivery with uterine leiomyomas: A population-based study [J].
Coronado, GD ;
Marshall, LM ;
Schwartz, SM .
OBSTETRICS AND GYNECOLOGY, 2000, 95 (05) :764-769
[6]   THE FREQUENCY OF UTERINE LEIOMYOMAS [J].
CRAMER, SF ;
PATEL, A .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 94 (04) :435-438
[7]   Natural history of uterine polyps and leiomyomata [J].
DeWaay, DJ ;
Syrop, CH ;
Nygaard, IE ;
Davis, WA ;
Van Voorhis, BJ .
OBSTETRICS AND GYNECOLOGY, 2002, 100 (01) :3-7
[8]  
Faerstein E, 2001, AM J EPIDEMIOL, V153, P1, DOI 10.1093/aje/153.1.1
[9]  
Flake GP, 2003, ENVIRON HEALTH PERSP, V111, P1037, DOI 10.1289/ehp.5787
[10]   Hysterectomy: Improving the patient's decision-making process [J].
Gambone, JC ;
Reiter, RC .
CLINICAL OBSTETRICS AND GYNECOLOGY, 1997, 40 (04) :868-877